# Alfapump® System in the Treatment of Refractory or Recurrent Ascites (POSEIDON Study)

> **NCT03973866** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Sequana Medical N.V.** · enrollment: 110 (actual)

## Conditions studied

- Ascites

## Interventions

- **DEVICE:** Alfapump

## Key facts

- **NCT ID:** NCT03973866
- **Lead sponsor:** Sequana Medical N.V.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-09-16
- **Primary completion:** 2024-03-30
- **Final completion:** 2024-06-30
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2022-12-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03973866

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03973866, "Alfapump® System in the Treatment of Refractory or Recurrent Ascites (POSEIDON Study)". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03973866. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*